Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Adrenal Cancer Diagnostics Market Grown from 2024 to 2025?

The market for adrenal cancer diagnostics has witnessed considerable growth in the past years. The market size is projected to increase from $140.35 billion in 2024 to $149.96 billion in 2025, signifying a compound annual growth rate (CAGR) of 6.8%. The expansion during the historical period can be traced back to a rise in cases and awareness, advancements in genetic and molecular testing, improved biopsy procedures, improved endocrine testing, and the incorporation of artificial intelligence (AI).

What Growth Rate Is Anticipated for the Adrenal Cancer Diagnostics Market in the Coming Years?

We foresee robust expansion in the adrenal cancer diagnostics market span, with predictions showing growth up to $193.26 billion in 2029, at a compound annual growth rate (CAGR) of 6.5%. Factors driving expansion in the forecast period encompass individualized medicine strategies, increased usage of minimally invasive methods, advancements in telemedicine and remote consultations, liquid biopsy enhancements, and broadened services in genetic counseling. Significant trends in the forecast timeframe include regulatory backing for innovative diagnoses, embracing of digital pathology, cutting-edge advancements in imaging technologies, further development of liquid biopsies, and genomic profiling for precision medicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13242&type=smp

Who Are the Leading Companies in the Adrenal Cancer Diagnostics Market?

Major companies operating in the adrenal cancer diagnostics market report are Johnson And Johnson Pvt Ltd., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, GSK PLC, AstraZeneca PLC, Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies, Hologic Inc., PerkinElmer Inc., Illumina Inc., Roche Diagnostics, BioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Exact Sciences Corp., Natera Inc., Invitae Corporation, Qiagen NV, Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc., TRS Technologies Inc., Morgan Advanced Materials, APC International Ltd., Annon Piezo Technology Co. Limited

What Are the Key Drivers of the Adrenal Cancer Diagnostics Market?

The expected escalation in cigarette smoking is anticipated to facilitate growth in the adrenal cancer diagnostics market. This activity pertains to taking in and releasing smoke from burning tobacco, which is imbibed with a highly addictive alkaloid known as nicotine. This offers both exciting and calming psychoactive impacts. There is a correlation between cigarette smoking and a heightened probability of adrenal cancer, involving adrenocortical carcinomas and adrenal adenomas. The DNA in adrenal cells can experience damage from the carcinogens present in tobacco smoke, which can lead to cancer-causing mutations. For example, in July 2022, as per Statistics Canada, a Canada-based governmental organization, there was a 5.8% increase in cigarette production compared to June 2021. Moreover, the total volume of cigarettes purchased grew by 1.3% from May 2022, culminating in 1.4 billion in June 2022. Thus, the increasing prevalence of cigarette smoking is a growth catalyst for the adrenal cancer diagnostics market. Actions undertaken by governing bodies in aid to cancer are anticipated to boost growth in the adrenal cancer diagnostics market. These ventures signify a marked rise in efforts made by governments to tackle and alleviate various calamities, problems, or crises. Such initiatives are representational in advocating early diagnosis, elevating the quality and availability of diagnostic services, bolstering research, and ultimately improving the efficacy of adrenal cancer diagnostics. For example, in April 2023, as per the NIH (National Institutes of Health), a US-based government agency specializing in biomedical and public health research, the Biden-Harris administration set up an initiative to reduce cancer-related fatalities by 50% within the subsequent 25 years, simultaneously augmenting the comprehension and support for individuals afflicted and surviving cancer. Hence, government initiatives in support of cancer are pivotal in driving the growth of the adrenal cancer diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13242&type=smp

What Are the Key Market Segments in the Adrenal Cancer Diagnostics Industry?

The adrenal cancer diagnostics market covered in this report is segmented –

1) By Test: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-ray, Positron Emission Tomography (PET) Scan, Biopsy

2) By Treatment: Surgery, Chemotherapy, Radiotherapy, Targeted Cancer Therapies, Other Treatments

3) By Tumor Type: Pheochromocytoma, Adrenal Cortical Carcinoma, Other Types

4) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Centers, Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Contrast-Enhanced MRI, Functional MRI

2) By Computed Tomography (CT) Scan: Contrast-Enhanced CT, Abdomen And Pelvis CT Scans

3) By X-ray: Standard X-ray Imaging, Specialized X-ray Techniques

4) By Positron Emission Tomography (PET) Scan: PET-CT Combination Scans, Standalone PET Scans

5) By Biopsy: Fine Needle Aspiration Biopsy (FNA), Core Needle Biopsy, Surgical Biopsy

What Are the Latest Trends in the Adrenal Cancer Diagnostics Market?

Leading firms in the adrenal cancer diagnostics market are fostering innovative strategies and advanced collaboration frameworks such as the CancerX Startup Accelerator to promote digital advancements in cancer treatment. The goal of the Accelerator is to equip promising new businesses with mentorship, education, and direct liaison with significant players in the healthcare sector, including service providers and pharmaceutical corporations. In November 2023, for example, CanceRx, LLC, an American public-private initiative aiming to stimulate innovation in battling cancer, declared the inauguration of this project at the Future of Cancer Care Summit held in Tampa, Florida. The program intends to inaugurate its first cohort of around 15 to 20 companies beginning in March 2024, concentrating on vital aspects like clinical investigation, screening, diagnosis, and treatment. It’s anticipated that this will heavily propel the objectives of the Cancer Moonshot initiative, by tackling unsatisfied requirements in cancer care and promoting the construction of effective digital healthcare tools in oncology.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/adrenal-cancer-diagnostics-global-market-report

What Are the Key Regional Markets in the Adrenal Cancer Diagnostics Industry?

North America was the largest region in the adrenal cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adrenal cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13242

This Report Delivers Insight On:

1. How big is the adrenal cancer diagnostics market, and how is it changing globally?

2. Who are the major companies in the adrenal cancer diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the adrenal cancer diagnostics market right now?

4. Which products or customer segments are growing the most in the adrenal cancer diagnostics market?

5. What factors are helping or slowing down the growth of the adrenal cancer diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model